Overview of the Secretary General’s High-Level Panel on Access to Medicines United Nations Secretary-General, Ban Ki-moon, on 19 November 2015, announced the appointment of the United Nations Secretary-General’s High-Level Panel on Access to Medicines (‘the High-Level Panel’). The formation of the High-Level Panel is in line with the ambitions of UN Member States as articulated in the 2030 Development Agenda and in support of attaining Sustainable Development Goal 3, to ensure healthy lives and promote the well-being of all. It builds on the findings and recommendations of the Global Commission on HIV and the Law. The High-Level Panel is comprised of 16 eminent, well-respected individuals with a deep knowledge and understanding of a broad range of trade, public health, human rights and legal issues associated with the promotion of innovation and access to medicines, vaccines, diagnostics and other health technologies. The CoChairs are Festus Mogae, former President of Botswana and Ruth Dreifuss, former President of Switzerland. The Secretary-Gene